3Lessey BA, Metzger DA, Haney AF et al . Immunohistoche mical analysis of estrogen and progesterone receptors in endometriosis: comparison with normal endometrium during the menstruad cycle and the effect of medical therapy. Fertil Steril, 1989,51:409-415.
4Kettel LM, Ulmann A, Murphy AA et al . Treatment of endometriosis with theantiprogesterone mifepristone( Ru486 ). Fertil teril, 1996,65:23-28.
5Kettel LM, Murphy AA, Mortola .JF et al . Endocrine responses to long term administration of the antiprogesterone Ru 486 in patients with pelvic endometriosis. Fetil Steril, 1991,56:402-407.
6Rein MS, Barbieri RL, Friedman AJ. Progester one: acritical role in the pathogenesis of uterine myomas. Am J Obstet Gynecol, 1995,172:14 - 18.
7Murphy AA, Kettel LM, Morales AJ et al . Regression of uterine leiomyomata in response to the antiprogesterone Ru 486. J Clin En docrinol Metab, 1993,76:513-517.
8Murphy AA, Morales AJ, Kettel LM et al . Regression of uterine leiomyomata to the antiprogesterone Ru 486: doseresponse effect.Fetil Steril, 1995,64:187- 190.
9HinesJF, GhimS, SchlegelRetal .Prospects for a vaccine against human papilloma virus. Obstet Gynecol, 1995, 86:860-866.
10Bartholomew JS, Glenville S, Sarkar S et al . Integration of high risk human papilloma virus DNA is linked to the down regulation of class I human leukocyte antigens by steroid hormones in cervical tumor cells.Cancer Res, 1997,57:937-942.
